Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Braze, Inc.BRZE · Entity 4102 | General Counsel & Corp. Sec. | May 29, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Braze, Inc.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 230,184 |
Reported balance
After 2026-05-29 transaction · row 1
1 source rowRow 1 · 2026-05-29 · Grant · Acquired 230,184 · Balance 230,184 F1: These shares represent a restricted stock unit ("RSU") award, which shall vest over three years with 40% of shares vesting on May 15, 2027, 35% of shares vesting in equal quarterly installments through May 15, 2028, and the remainder of the shares vesting in equal quarterly installments thereafter. The vesting of the RSUs are subject to the Reporting Person's continuous service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent a restricted stock unit ("RSU") award, which shall vest over three years with 40% of shares vesting on May 15, 2027, 35% of shares vesting in equal quarterly installments through May 15, 2028, and the remainder of the shares vesting in equal quarterly installments thereafter. The vesting of the RSUs are subject to the Reporting Person's continuous service through each vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Alteryx, Inc.
Report date March 19, 2024 · Filed March 19, 2024
Section 16 reporting ended · disclosed 2024-03-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-03-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-03-19 · Disposition to issuer · Disposed 79,509 · Balance 38,492 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F2: At the effective time of the Merger, these shares were automatically converted solely into the right to receive cash in an amount equal to $48.25, without interest, per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement. Row 2 · 2024-03-19 · Disposition to issuer · Disposed 38,492 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F3: At the effective time of the Merger, each outstanding restricted stock unit that was unvested was cancelled and converted solely into the contingent right to receive a cash award (without interest) equal to (i) the total number of shares of common stock subject to such unvested restricted stock unit award immediately prior to the effective time of the Merger, multiplied by (ii) the Per Share Price, less applicable withholding taxes. Such resulting cash award and payment thereof will be subject to the same vesting terms and conditions as applied to such unvested restricted stock unit award immediately prior to the effective time of the Merger. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.26 · Expires 2029-03-03 | Direct | 0 |
Reported balance
After 2024-03-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-03-19 · Disposition to issuer · Disposed 7,046 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F4: At the effective time of the Merger, this option to purchase shares of the Issuer's common stock had an exercise price per share that was greater than or equal to the Per Share Price and, pursuant to the terms of the Merger Agreement, was cancelled for no consideration or payment. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.09 · Expires 2028-01-05 | Direct | 0 |
Reported balance
After 2024-03-19 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-03-19 · Disposition to issuer · Disposed 9,389 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F5: At the effective time of the Merger, each issued and outstanding stock option that was vested was cancelled and converted solely into the right to receive an amount in cash (without interest) equal to (i) the total number of shares of common stock subject to such vested option multiplied by (ii) the excess, if any, of the Per Share Price over the exercise price per share of such vested option, less applicable withholding taxes, subject to the terms and conditions of the Merger Agreement. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2029-09-13 | Direct | 0 |
Reported balance
After 2024-03-19 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-03-19 · Disposition to issuer · Disposed 90,000 · Balance 0 F6: This award of performance-based restricted stock units had not become eligible for vesting as of the effective time of the Merger based on the actual or deemed achievement of the applicable performance-based metrics and, pursuant to the terms of the award agreement under which this award was granted and the Merger Agreement, was cancelled for no consideration or payment. F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent.
F2: At the effective time of the Merger, these shares were automatically converted solely into the right to receive cash in an amount equal to $48.25, without interest, per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement.
F3: At the effective time of the Merger, each outstanding restricted stock unit that was unvested was cancelled and converted solely into the contingent right to receive a cash award (without interest) equal to (i) the total number of shares of common stock subject to such unvested restricted stock unit award immediately prior to the effective time of the Merger, multiplied by (ii) the Per Share Price, less applicable withholding taxes. Such resulting cash award and payment thereof will be subject to the same vesting terms and conditions as applied to such unvested restricted stock unit award immediately prior to the effective time of the Merger.
F4: At the effective time of the Merger, this option to purchase shares of the Issuer's common stock had an exercise price per share that was greater than or equal to the Per Share Price and, pursuant to the terms of the Merger Agreement, was cancelled for no consideration or payment.
F5: At the effective time of the Merger, each issued and outstanding stock option that was vested was cancelled and converted solely into the right to receive an amount in cash (without interest) equal to (i) the total number of shares of common stock subject to such vested option multiplied by (ii) the excess, if any, of the Per Share Price over the exercise price per share of such vested option, less applicable withholding taxes, subject to the terms and conditions of the Merger Agreement.
F6: This award of performance-based restricted stock units had not become eligible for vesting as of the effective time of the Merger based on the actual or deemed achievement of the applicable performance-based metrics and, pursuant to the terms of the award agreement under which this award was granted and the Merger Agreement, was cancelled for no consideration or payment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2020 Filed Apr 17, 2020 16:51 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 615 | $114.24 | $70,257.60 |
DisclosureSEC source: 0001689923-20-000020 · wf-form4_158715668248031.xml · nonDerivative · entry 5 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,922 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.72 to $114.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 16:51 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass A Common Stock | 2,920 | $68.26 | $199,319.20 |
DisclosureSEC source: 0001689923-20-000020 · wf-form4_158715668248031.xml · nonDerivative · entry 4 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 16:51 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass A Common Stock | 1,834 | $27.09 | $49,683.06 |
DisclosureSEC source: 0001689923-20-000020 · wf-form4_158715668248031.xml · nonDerivative · entry 3 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 16:51 UTC | Alteryx, Inc. AYX · Entity 92794 | ConversionClass A Common Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001689923-20-000020 · wf-form4_158715668248031.xml · nonDerivative · entry 2 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 16:51 UTC | Alteryx, Inc. AYX · Entity 92794 | ConversionClass A Common Stock | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001689923-20-000020 · wf-form4_158715668248031.xml · nonDerivative · entry 1 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 21:34 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,460 | $0.00 Strike: $27.09 | $0.00 |
DisclosureSEC source: 0001689923-20-000011 · wf-form4_158510005631248.xml · derivative · entry 3 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,301 Underlying: Class A Common Stock · 1,460 shares Expires 2028-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vested and became exercisable as to 1/4th of the shares subject to the option on January 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 21:34 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 1,460 | $100.96 | $147,401.60 |
DisclosureSEC source: 0001689923-20-000011 · wf-form4_158510005631248.xml · nonDerivative · entry 2 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,697 F2 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F1 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 21:34 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass A Common Stock | 1,460 | $27.09 | $39,551.40 |
DisclosureSEC source: 0001689923-20-000011 · wf-form4_158510005631248.xml · nonDerivative · entry 1 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionStock Option (Right to Buy) · Derivative | 218 | $0.00 Strike: $27.09 | $0.00 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · derivative · entry 21 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,761 Underlying: Class A Common Stock · 218 shares Expires 2028-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F18 · derivative.exercise_date: The stock option vested and became exercisable as to 1/4th of the shares subject to the option on January 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 218 | $85.00 | $18,530.00 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 16 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,697 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass A Common Stock | 218 | $27.09 | $5,905.62 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 15 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,985 | $0.00 Strike: $27.09 | $0.00 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · derivative · entry 20 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,979 Underlying: Class A Common Stock · 1,985 shares Expires 2028-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F18 · derivative.exercise_date: The stock option vested and became exercisable as to 1/4th of the shares subject to the option on January 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | ConversionClass B Common Stock · Derivative | 2,177 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · derivative · entry 19 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,177 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F17 · derivative.exercise_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F17 · derivative.expiration_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass B Common Stock · Derivative | 2,177 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · derivative · entry 18 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,177 Underlying: Class A Common Stock · 2,177 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F17 · derivative.exercise_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F17 · derivative.expiration_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,177 | $0.00 Strike: $12.30 | $0.00 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · derivative · entry 17 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,561 Underlying: Class B Common Stock · 2,177 shares Expires 2026-11-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_date: The stock option vested and became exercisable as to 1/4th of the shares subject to the option on November 29, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 612 | $94.48 | $57,821.76 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 14 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,697 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.21 to $94.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 368 | $93.62 | $34,452.16 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 13 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,309 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.06 to $94.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 214 | $92.52 | $19,799.28 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 12 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,677 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.04 to $93.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 204 | $91.34 | $18,633.36 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 11 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,891 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.89 to $91.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 277 | $89.23 | $24,716.71 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 10 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,095 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.76 to $89.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 497 | $88.00 | $43,736.00 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 9 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,372 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.43 to $88.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 980 | $86.88 | $85,142.40 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 8 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,869 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.39 to $87.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 278 | $85.80 | $23,852.40 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 7 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,849 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.34 to $86.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 311 | $84.85 | $26,388.35 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 6 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,127 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.33 to $85.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 80 | $82.53 | $6,602.40 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 5 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,438 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.51 to $82.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 140 | $81.64 | $11,429.60 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 4 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,518 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.45 to $81.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 201 | $80.35 | $16,150.35 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 3 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,658 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.19 to $80.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass A Common Stock | 1,985 | $27.09 | $53,773.65 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 2 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 17:17 UTC | Alteryx, Inc. AYX · Entity 92794 | ConversionClass A Common Stock | 2,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001689923-20-000010 · wf-form4_158456624695622.xml · nonDerivative · entry 1 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 18:13 UTC | Alteryx, Inc. AYX · Entity 92794 | GrantStock Option (Right to Buy) · Derivative | 15,540 | $0.00 Strike: $153.26 | $0.00 |
DisclosureSEC source: 0001426395-20-000005 · wf-form4_158232677410855.xml · derivative · entry 2 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,540 Underlying: Class A Common Stock · 15,540 shares Expires 2030-02-18 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/3rd of the shares subject to the option on January 1, 2021, and thereafter vests as to 1/36th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the status of "Participant's Service" (as defined in the 2017 Equity Incentive Plan) through each vesting date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 18:13 UTC | Alteryx, Inc. AYX · Entity 92794 | GrantClass A Common Stock | 7,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001426395-20-000005 · wf-form4_158232677410855.xml · nonDerivative · entry 1 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,697 F1 · shares: Represents an award of restricted stock units ("RSUs"). 1/3rd of the total RSUs will vest on January 1, 2021, and on each yearly anniversary thereafter, subject to the status of "Participant's Service" (as defined in the 2017 Equity Incentive Plan) through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. F2 · balance_after: Includes (i) 19,369 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,460 | $0.00 Strike: $68.26 | $0.00 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · derivative · entry 12 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,473 Underlying: Class A Common Stock · 1,460 shares Expires 2029-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The stock option vested and became exercisable as to 1/3rd of the shares subject to the option on January 1, 2020, and thereafter vests as to 1/36th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | ConversionClass B Common Stock · Derivative | 4,380 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · derivative · entry 11 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F11 · derivative.exercise_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F11 · derivative.expiration_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass B Common Stock · Derivative | 4,380 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · derivative · entry 10 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 Underlying: Class A Common Stock · 4,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F11 · derivative.exercise_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F11 · derivative.expiration_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,380 | $0.00 Strike: $12.30 | $0.00 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · derivative · entry 9 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,738 Underlying: Class B Common Stock · 4,380 shares Expires 2026-11-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock option vested and became exercisable as to 1/4th of the shares subject to the option on November 29, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 724 | $159.61 | $115,557.64 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · nonDerivative · entry 8 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,576 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.22 to $159.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 1,339 | $158.65 | $212,432.35 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · nonDerivative · entry 7 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.15 to $159.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 1,908 | $157.60 | $300,700.80 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · nonDerivative · entry 6 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,639 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.15 to $158.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 929 | $156.57 | $145,453.53 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · nonDerivative · entry 5 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,547 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.08 to $156.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 717 | $155.53 | $111,515.01 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · nonDerivative · entry 4 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,476 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.04 to $155.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 223 | $154.22 | $34,391.06 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · nonDerivative · entry 3 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,193 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.91 to $154.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass A Common Stock | 1,460 | $68.26 | $99,659.60 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · nonDerivative · entry 2 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 20:37 UTC | Alteryx, Inc. AYX · Entity 92794 | ConversionClass A Common Stock | 4,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001426395-20-000004 · wf-form4_158216265196076.xml · nonDerivative · entry 1 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 345 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2020. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 19:37 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,460 | $0.00 Strike: $27.09 | $0.00 |
DisclosureSEC source: 0001426395-20-000003 · wf-form4_157922145524446.xml · derivative · entry 14 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,964 Underlying: Class A Common Stock · 1,460 shares Expires 2028-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The stock option vested and became exercisable as to 1/4th of the shares subject to the option on January 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 19:37 UTC | Alteryx, Inc. AYX · Entity 92794 | ConversionClass B Common Stock · Derivative | 4,380 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001426395-20-000003 · wf-form4_157922145524446.xml · derivative · entry 13 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F12 · derivative.exercise_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F12 · derivative.expiration_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 19:37 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionClass B Common Stock · Derivative | 4,380 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001426395-20-000003 · wf-form4_157922145524446.xml · derivative · entry 12 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 Underlying: Class A Common Stock · 4,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F12 · derivative.exercise_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date F12 · derivative.expiration_date: Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 19:37 UTC | Alteryx, Inc. AYX · Entity 92794 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,380 | $0.00 Strike: $12.30 | $0.00 |
DisclosureSEC source: 0001426395-20-000003 · wf-form4_157922145524446.xml · derivative · entry 11 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,118 Underlying: Class B Common Stock · 4,380 shares Expires 2026-11-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The stock option vested and became exercisable as to 1/4th of the shares subject to the option on November 29, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 19:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 42 | $127.59 | $5,358.78 |
DisclosureSEC source: 0001426395-20-000003 · wf-form4_157922145524446.xml · nonDerivative · entry 10 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,386 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 155 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2019. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 19:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 987 | $126.98 | $125,329.26 |
DisclosureSEC source: 0001426395-20-000003 · wf-form4_157922145524446.xml · nonDerivative · entry 9 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,428 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.49 to $127.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 155 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2019. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 19:37 UTC | Alteryx, Inc. AYX · Entity 92794 | SaleClass A Common Stock | 880 | $125.61 | $110,536.80 |
DisclosureSEC source: 0001426395-20-000003 · wf-form4_157922145524446.xml · nonDerivative · entry 8 Lal Christopher M · CIK 0001426395 · CLO & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,415 F3 · shares: Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on May 24, 2019. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.28 to $126.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: Includes (i) 12,248 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting; and (ii) 155 shares acquired under the Alteryx, Inc. employee stock purchase plan through February 14, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.